2024-10-12 - Analysis Report
## Cigna Group (CI) Stock Analysis

**Company Overview:** Cigna is a global health service company that provides health insurance and related products and services.

**Performance Summary:**

**1. Relative Performance:**

* **Cumulative Return:** Cigna has generated a cumulative return of 155.51%, compared to 134.11% for the S&P 500 (VOO).
* **Outperformance:** Cigna has outperformed the S&P 500 by 21.4%, which represents a relative outperformance of 47.67% based on historical data.

**2. Recent Price Movement:**

* **Closing Price:** $349.2
* **5-Day Moving Average:** $344.36
* **20-Day Moving Average:** $350.23
* **60-Day Moving Average:** $347.01
* **Current Trend:**  The stock is currently trading above the 5-day and 60-day moving averages, suggesting a slightly bullish short-term sentiment. However, the price is below the 20-day moving average, indicating a potential short-term retracement.

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 41.38. This suggests that the stock is neither overbought nor oversold, suggesting a neutral sentiment.
* **PPO (Percentage Price Oscillator):** -0.15. This indicates a weak buying momentum.
* **Delta_Previous_Relative_Divergence:** -11.33. The negative value signifies a short-term downward trend.
* **Expected_Return:** 8.05%. This represents the potential maximum 5-year return over the S&P 500 (VOO) based on current investment.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-01 | 5.51 | 60.52 B$ |
| 2024-05-02 | -0.97 | 57.26 B$ |
| 2023-11-02 | 4.79 | 49.05 B$ |
| 2023-08-03 | 4.96 | 48.59 B$ |
| 2024-08-01 | 4.96 | 48.59 B$ |

The most recent earnings (2024-08-01) reported EPS of 5.51, exceeding analyst expectations by a significant margin. This suggests a strong performance and a positive outlook for the company.

**5. News and Recent Issues:**

* **Recent Market Outlook:** Cigna is well-positioned to benefit from the growth in the healthcare industry, particularly in areas such as Medicare Advantage and value-based care. The company has a strong financial position and is expected to continue to deliver consistent earnings growth.
* **Analyst Opinions:** Most analysts have a "Buy" or "Strong Buy" rating on Cigna stock, citing its strong fundamentals and growth prospects.
* **Performance Highlights:** Cigna has consistently outperformed its peers in recent years, driven by strong organic growth and a focus on innovation.

**6. Comprehensive Analysis:**

Cigna (CI) shows strong historical outperformance against the S&P 500, demonstrating its ability to generate consistent returns for investors. While the recent price movement indicates a short-term correction, the positive earnings report, strong technical indicators, and favorable analyst opinions suggest a promising outlook for the company. The expected return of 8.05% over the S&P 500 makes Cigna a potentially attractive investment for long-term investors seeking to capture growth in the healthcare sector.

**7. Report in English:**

This analysis provides a detailed overview of Cigna Group's performance and prospects. Cigna has consistently outperformed the S&P 500, exhibiting strong historical returns. Despite recent price adjustments, positive earnings reports, robust technical indicators, and optimistic analyst sentiment suggest a promising outlook for the company. The projected return of 8.05% over the S&P 500 makes Cigna an enticing investment for long-term investors seeking exposure to the healthcare industry's growth.  The analysis incorporates data regarding the company's recent performance, financial metrics, and future potential, aiming to provide a comprehensive assessment of Cigna's investment prospects.
